Helsinn is a fully integrated biopharma company with a strong focus on oncology and rare diseases. With over forty years of commercial execution, Helsinn is a leader in supportive care, aiming to improve the health and quality of life of patients with cancer and chronic conditions.
Focus Areas
Notable Investments
